New Delhi, Dec 23 (IANS) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet.”The induction of antibodies within 1 month of vaccination, along with the persistence afforded by two dosages, suggests the vaccine ca…
Trending
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard
- Licence Review (2026): Masoom Sharma Delivers a Gripping Haryanvi Crime Drama
- Bhagubai (2026) Review: Nirmiti Sawant Shines in This Heartfelt Marathi Village Drama
- Ginny Wedss Sunny 2 Review (2026): A Warm and Relatable Ride Through the Chaos of Arranged Marriage
- Jerax Review (2026): Nagabhushan’s Supernatural Thriller Is a Wildly Entertaining Ride
- Battle (2026) Movie Review — Tamil Rap Drama Finds Its Rhythm in Flashes
- Madhuvidhu Movie Review (2026): Sharaf U Dheen’s Charm Lights Up This Warm Malayalam Rom-Com